Matthew Taylor
Stock Analyst at Jefferies
(2.66)
# 2,004
Out of 5,122 analysts
184
Total ratings
60.36%
Success rate
10.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Matthew Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Downgrades: Hold | $335 → $374 | $356.00 | +5.06% | 2 | Jan 16, 2026 | |
| GEHC GE HealthCare Technologies | Maintains: Buy | $95 → $105 | $78.78 | +33.28% | 3 | Dec 11, 2025 | |
| PODD Insulet | Maintains: Neutral | $320 → $355 | $251.22 | +41.31% | 16 | Nov 7, 2025 | |
| EW Edwards Lifesciences | Upgrades: Buy | $80 → $98 | $82.10 | +19.37% | 20 | Oct 29, 2025 | |
| SI Shoulder Innovations | Initiates: Buy | $19 | $13.39 | +41.90% | 1 | Aug 25, 2025 | |
| ABT Abbott Laboratories | Upgrades: Buy | $143 → $145 | $109.02 | +33.00% | 17 | Jul 18, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $15.90 | -5.66% | 7 | Apr 14, 2025 | |
| MDT Medtronic | Maintains: Sell | $75 → $76 | $103.18 | -26.34% | 17 | May 24, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $125 | $1.35 | +9,159.26% | 1 | Feb 9, 2024 | |
| MASI Masimo | Downgrades: Hold | $107 → $121 | $139.13 | -13.03% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $14 | $4.08 | +243.14% | 1 | Jan 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $47 → $45 | $19.44 | +131.48% | 2 | Oct 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $10 | $7.13 | +40.25% | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $53 | $10.78 | +391.65% | 2 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $22 → $24 | $13.93 | +72.29% | 2 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $345 | $360.82 | -4.38% | 14 | May 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Hold | $115 → $130 | $86.18 | +50.85% | 8 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $16.26 | +23.00% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $85 | $38.79 | +119.13% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $75 | $87.45 | -14.24% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $245 | $251.41 | -2.55% | 7 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $62 | $19.91 | +211.40% | 8 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $102.37 | +105.14% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $14.67 | -18.20% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $71.63 | +74.51% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $91.62 | -45.43% | 1 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $210 | $478.88 | -56.15% | 12 | Oct 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $96 | $65.93 | +45.61% | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $3.93 | +78.12% | 1 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $266 | $206.50 | +28.81% | 4 | May 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $17 → $16 | $10.64 | +50.38% | 2 | Jul 19, 2017 |
Penumbra
Jan 16, 2026
Downgrades: Hold
Price Target: $335 → $374
Current: $356.00
Upside: +5.06%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Buy
Price Target: $95 → $105
Current: $78.78
Upside: +33.28%
Insulet
Nov 7, 2025
Maintains: Neutral
Price Target: $320 → $355
Current: $251.22
Upside: +41.31%
Edwards Lifesciences
Oct 29, 2025
Upgrades: Buy
Price Target: $80 → $98
Current: $82.10
Upside: +19.37%
Shoulder Innovations
Aug 25, 2025
Initiates: Buy
Price Target: $19
Current: $13.39
Upside: +41.90%
Abbott Laboratories
Jul 18, 2025
Upgrades: Buy
Price Target: $143 → $145
Current: $109.02
Upside: +33.00%
InMode
Apr 14, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $15.90
Upside: -5.66%
Medtronic
May 24, 2024
Maintains: Sell
Price Target: $75 → $76
Current: $103.18
Upside: -26.34%
Allurion Technologies
Feb 9, 2024
Initiates: Buy
Price Target: $125
Current: $1.35
Upside: +9,159.26%
Masimo
Jan 30, 2024
Downgrades: Hold
Price Target: $107 → $121
Current: $139.13
Upside: -13.03%
Jan 19, 2024
Initiates: Buy
Price Target: $14
Current: $4.08
Upside: +243.14%
Oct 2, 2023
Maintains: Buy
Price Target: $47 → $45
Current: $19.44
Upside: +131.48%
Jul 19, 2023
Initiates: Underperform
Price Target: $10
Current: $7.13
Upside: +40.25%
Jul 12, 2023
Upgrades: Buy
Price Target: $58 → $53
Current: $10.78
Upside: +391.65%
May 24, 2023
Maintains: Hold
Price Target: $22 → $24
Current: $13.93
Upside: +72.29%
May 2, 2023
Maintains: Buy
Price Target: $320 → $345
Current: $360.82
Upside: -4.38%
Mar 31, 2023
Upgrades: Hold
Price Target: $115 → $130
Current: $86.18
Upside: +50.85%
Oct 12, 2022
Initiates: Buy
Price Target: $20
Current: $16.26
Upside: +23.00%
Oct 12, 2022
Initiates: Hold
Price Target: $85
Current: $38.79
Upside: +119.13%
Oct 12, 2022
Initiates: Buy
Price Target: $75
Current: $87.45
Upside: -14.24%
Oct 12, 2022
Initiates: Hold
Price Target: $245
Current: $251.41
Upside: -2.55%
Oct 12, 2022
Initiates: Hold
Price Target: $62
Current: $19.91
Upside: +211.40%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $102.37
Upside: +105.14%
Oct 12, 2022
Initiates: Buy
Price Target: $12
Current: $14.67
Upside: -18.20%
Oct 12, 2022
Initiates: Buy
Price Target: $125
Current: $71.63
Upside: +74.51%
Oct 12, 2022
Initiates: Buy
Price Target: $50
Current: $91.62
Upside: -45.43%
Oct 12, 2022
Initiates: Hold
Price Target: $210
Current: $478.88
Upside: -56.15%
Feb 24, 2022
Upgrades: Buy
Price Target: $96
Current: $65.93
Upside: +45.61%
Dec 17, 2021
Initiates: Neutral
Price Target: $7
Current: $3.93
Upside: +78.12%
May 13, 2019
Upgrades: Overweight
Price Target: $266
Current: $206.50
Upside: +28.81%
Jul 19, 2017
Maintains: Equal-Weight
Price Target: $17 → $16
Current: $10.64
Upside: +50.38%